Related Experiment Videos
NT-4/5 reduces naturally occurring retinal ganglion cell death in neonatal rats
1Department of Anatomy and Human Biology, University of Western Australia, Nedlands, Perth.
Abstract:
The retrograde nucleophilic tracer diamidino yellow (DY) was injected into the left superior colliculi of 2-day-old rats. Two days later, right eyes were injected with either neurotrophin NT-4/5, cycloheximide (CHX), MK-801 and DNQX (glutamate receptor antagonists), or saline. Almost all rats were perfused 6-7 h later and the numbers of normal and pyknotic DY-labelled retinal ganglion cells (RGCs) were determined from retinal whole mounts. In controls (no eye injection) the proportion of pyknotic RGCs was 1.04%. This level of naturally occurring death was significantly reduced after injection of NT-4/5 (0.34%); normal RGC density was also higher in this group. RGC pyknosis was increased after saline (1.21%), MK-801/DNQX (1.22%) or CHX (1.48%) injections but only in the latter case was the increase significantly greater than control.
Insights
Neurotrophin NT-4/5 reduced naturally occurring death in retinal ganglion cells (RGCs). Other tested substances like cycloheximide increased RGC death, highlighting factors influencing RGC survival.
Area of Science:
- Neuroscience
- Developmental Biology
- Cell Biology
Background:
- Retinal ganglion cells (RGCs) undergo programmed cell death during development.
- Understanding factors that regulate RGC survival is crucial for treating vision loss.
- Neurotrophins are known to play a role in neuronal survival.
Purpose of the Study:
- To investigate the effects of neurotrophin NT-4/5 and other agents on RGC survival in young rats.
- To determine the impact of glutamate receptor antagonists and cycloheximide on RGC death.
- To quantify naturally occurring RGC death and its modulation by experimental interventions.
Main Methods:
- Retrograde labeling of RGCs using diamidino yellow (DY) injected into the superior colliculi of 2-day-old rats.
- Post-labeling eye injections with neurotrophin NT-4/5, cycloheximide (CHX), MK-801/DNQX, or saline.
- Analysis of normal and pyknotic (dying) DY-labeled RGCs in retinal whole mounts 6-7 hours post-injection.
Main Results:
- Neurotrophin NT-4/5 significantly reduced the proportion of pyknotic RGCs (0.34%) compared to controls (1.04%).
- NT-4/5 treatment also resulted in higher normal RGC density.
- Saline, MK-801/DNQX, and CHX injections showed increased RGC pyknosis, with CHX causing a significant increase above control levels.
Conclusions:
- Neurotrophin NT-4/5 promotes RGC survival and reduces naturally occurring cell death in early postnatal development.
- Glutamate receptor antagonists and cycloheximide do not significantly protect RGCs and may increase cell death.
- These findings underscore the neuroprotective potential of NT-4/5 for retinal ganglion cells.